All text is © British Library Board and is available under a Creative Commons Attribution Licence, except where otherwise stated.
Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
![]() |
Prophylactic cranial irradiation in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO expertsPutora, Paul M. et al.Radiotherapy and oncology. Volume 133 (2019); pp 163-166 -- Elsevier Ireland LtdOnline access |
2 |
Material Type: Article
|
![]() |
Prophylactic cranial irradiation in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO expertsPutora, Paul M. et al.Radiotherapy and oncology. Volume 133: (2019, April); pp 163-166 -- Elsevier Ireland LtdOnline access |
3 |
Material Type: Article
|
![]() |
Consolidative thoracic radiotherapy in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO expertsPutora, Paul Martin et al.Radiotherapy and oncology. Volume 135 (2019); pp 74-77 -- Elsevier Ireland LtdOnline access |
4 |
Material Type: Article
|
![]() |
Erratum to "Consolidative thoracic radiotherapy in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts" [Radiother. Oncol. 135 (2019) 74–77]Putora, Paul MartinRadiotherapy and oncology. Volume 141: (2019, December); pp 332- -- Elsevier Ireland LtdOnline access |
5 |
Material Type: Article
|
![]() |
Consolidative thoracic radiotherapy in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO expertsPutora, Paul Martin et al.Radiotherapy and oncology. Volume 135: (2019, June); pp 74-77 -- Elsevier Ireland LtdOnline access |
6 |
Material Type: Article
|
![]() |
Erlotinib and bevacizumab in patients with advanced non-small-cell lung cancer and activating EGFR mutations (BELIEF): an international, multicentre, single-arm, phase 2 trialRosell, RafaelThe lancet. Respiratory medicine. Volume 5:Number 5 (2017, May); pp 435-444 -- ElsevierOnline access |
7 |
Material Type: Article
|
![]() |
Erlotinib and bevacizumab in patients with advanced non-small-cell lung cancer and activating EGFR mutations (BELIEF): an international, multicentre, single-arm, phase 2 trialRosell, Rafael et al.The lancet. Respiratory medicine. Volume 5:Issue 5 (2017); pp 435-444 -- ElsevierOnline access |